BATTELLE: CO & CMC PHARMACEUTICALS AWARDED $40 MLN FIVE-YEAR ARDAP PROGRAM BY U.S. DOW CONTRACT TO DEVELOP NERVE AGENT COUNTERMEASURES

Reuters · 3d ago

Please log in to view news